Omeros (OMER) Total Debt (2010 - 2026)
Omeros' (OMER) quarterly Total Debt came in at $52.8 million in Q1 2026, down 45.74% year-on-year from $97.3 million in Q1 2025, and down 22.82% quarter-over-quarter from $68.4 million in Q4 2025.
Omeros (OMER) Total Debt (2010 - 2026) Analysis & Trends
Omeros has disclosed Total Debt across 17 years of filings, most recently posting $52.8 million for Q1 2026.
- Total Debt for Q1 2026 came in at $52.8 million, down 45.74% year-over-year; the trailing twelve-month figure through Mar 2026 was $52.8 million (down 45.74% YoY), and the FY2025 annual result was $68.4 million, down 24.51% from the prior year.
- Total Debt came in at $52.8 million for Q1 2026 at Omeros, down from $68.4 million in the prior quarter.
- In the past five years, Total Debt ranged from a high of $316.7 million in Q3 2023 to a low of $52.8 million in Q1 2026.
- The 5-year median for Total Debt is $213.2 million (2023), against an average of $193.5 million.
- Across the five-year window, Total Debt grew 0.61% in 2023 and slumped 70.82% in 2024, its largest moves.
- Omeros' Total Debt stood at $315.3 million in 2022, then tumbled by 32.39% to $213.2 million in 2023, then slumped by 57.48% to $90.6 million in 2024, then retreated by 24.51% to $68.4 million in 2025, then decreased by 22.82% to $52.8 million in 2026.
- The last three Total Debt figures came in at $52.8 million (Q1 2026), $68.4 million (Q4 2025), and $72.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 319.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Omeros | 737.87 Mn | 602.55 Mn | 9.31 Mn | 52.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 52.81 Mn |
| Dec 31, 2025 | 68.43 Mn |
| Sep 30, 2025 | 72.08 Mn |
| Jun 30, 2025 | 87.31 Mn |
| Mar 31, 2025 | 97.33 Mn |
| Dec 31, 2024 | 90.64 Mn |
| Sep 30, 2024 | 92.43 Mn |
| Jun 30, 2024 | 94.51 Mn |
| Mar 31, 2024 | 213.46 Mn |
| Dec 31, 2023 | 213.16 Mn |
| Sep 30, 2023 | 316.74 Mn |
| Jun 30, 2023 | 316.25 Mn |
| Mar 31, 2023 | 315.76 Mn |
| Dec 31, 2022 | 315.29 Mn |
| Sep 30, 2022 | 314.82 Mn |
| Jun 30, 2022 | 314.36 Mn |
| Mar 31, 2022 | 313.90 Mn |
| Dec 31, 2021 | 313.46 Mn |
| Sep 30, 2021 | 313.02 Mn |
| Jun 30, 2021 | 312.59 Mn |